HUA CHEN to Cost-Benefit Analysis
This is a "connection" page, showing publications HUA CHEN has written about Cost-Benefit Analysis.
Connection Strength
0.069
-
High- versus low-dose fluconazole therapy for empiric treatment of suspected invasive candidiasis among high-risk patients in the intensive care unit: a cost-effectiveness analysis. Curr Med Res Opin. 2007 May; 23(5):1057-65.
Score: 0.053
-
Impact of changes in reimbursement policies and institutional practice algorithm for utilization of erythropoietic-stimulating agents on treatment patterns and costs in anemic lymphoma patients. Support Care Cancer. 2010 Feb; 19(2):251-9.
Score: 0.016